Aesthetic tourism has exploded, with a sharp 40% rise in travelers from Singapore and Malaysia booking cosmetic treatments in Bangkok and Seoul this January 2026. Driven by K-beauty and Thai wellness hubs, platforms like Klook and Trip.com report surges in Botox, fillers, laser skin, rhinoplasty, and double eyelid surgery packages combining procedures with stays. The leading hospitals in Bangkok, Bumrungrad and Yanhee, and Seoul, ID and TL clinics, provide 50-70% discounts compared to their home prices as a result of self-care behavior following the pandemic. The 1.17M foreign patients into South Korea in 2024 (68% aesthetic) and the 3M medical tourists in Thailand underscore the power of Asia, which is driven by Instagram influencers and the visa facilitation. Researchers forecast that there will be 21.95B beauty tourism in the world by 2026.
Bumrungrad sees Singaporeans for fillers, lasers at THB 10k-50k vs SGD 2k-5k home.
TL Hospital draws Malaysians for eyelids, Botox; 85% Seoul patients from Asia.
Disclaimer: Stay updated with the latest news in Thailand from politics to business trends, while also catching up on the latest news in sports covering matches, scores, and tournaments. Explore the latest news in entertainment with celebrity updates, movies, and shows, and don’t miss the latest news in games, featuring trending releases and esports highlights.
The Swiss open 2026 has again thrown the limelight on the best women doubles couple Pearly Tan and Thinaah Muralitharan…
Reports on the withdrawal of Heeseung, who is an internationally famous boy band ENHYPEN, cut the hearts of its fans…
Asia Based on viewers of Thai drama, episode 17 of The Heart of Yiwha is a hotly anticipated program in…
The time is near at hand to the anime fans. The new season of One Piece, the second one, has…
Nikko Natividad, a Filipino actor and former member of Hashtags, got a lot of attention online after an alleged intimate…
The romantic drama Crash Landing on You came out in 2019 and was almost instantly adopted by audiences all over…
This website uses cookies.
Read More